In this study, we reported for the first time that loganin inhibits Ang II–induced cardiac hypertrophy and cardiac damage in vivo and in vitro. Furthermore, our results suggested that loganin markedly ameliorates cardiac fibrosis and inflammation induced by Ang II. Here, AGT is linked to fibrosis.